Cat. #157975
BR58 cell line
Cat. #: 157975
Unit size: 1x10^6 cells / vial
Availability: 10-12 weeks
Organism: Human
Tissue: Breast
Disease: Cancer
Model: Tumour line
£575.00
This fee is applicable only for non-profit organisations. If you are a for-profit organisation or a researcher working on commercially-sponsored academic research, you will need to contact our licensing team for a commercial use license.
Contributor
Inventor: Tamar Peretz
Institute: Hadassah Medical Center; Hadasit Medical Research Services and Development Ltd.
Tool Details
*FOR RESEARCH USE ONLY (for other uses, please contact the licensing team)
- Name: BR58 cell line
- Cancer: Gynaecologic cancer
- Cancers detailed: Ovarian
- Research fields: Cancer;Drug development
- Organism: Human
- Tissue: Breast
- Disease: Cancer
- Model: Tumour line
- Description: This is an ovary cancer patient's derived cell line. Histology of serous papillary carcinoma. The line is derived from breast metastasis and it is positive for the BRCA1 c.68_69delAG, p.Glu23Valfs*17 (185delAG) mutation. When implanted to NSG mice it forms tumors. This line can serve as a platform for drug screening for cancer cells in vitro and in vivo.
- Production details: The cells were derived from metastasis (pleural effusion) in a patient with serous papillary carcinoma.
Target Details
- Target: Ovary Cancer
Handling
- Format: Frozen
- Growth medium: The base medium for this cell line is DMEM with 10% bovine serum.
- Unit size: 1x10^6 cells / vial
- Shipping conditions: Dry ice
Related Tools
- Related tools: BR45 cell line ; BR98 cell line
